Monopar Therapeutics (MNPR) Other Working Capital Changes (2017 - 2025)
Monopar Therapeutics (MNPR) posted Other Working Capital Changes of -$709403.0 for Q4 2025, down 761.5% sequentially from $107242.0 in Q3 2025, and down 2484.39% YoY from $29752.0 in Q4 2024.
Monopar Therapeutics (MNPR) Other Working Capital Changes (2017 - 2025) Analysis & Trends
Monopar Therapeutics has reported Other Working Capital Changes for 9 years, with the latest figure at -$709403.0 in Q4 2025.
- Quarterly Other Working Capital Changes fell 2484.39% year-over-year to -$709403.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$15404.0 (down 220.57% YoY) and the FY2025 annual result came in at -$15404.0, down 220.57% from the prior year.
- Other Working Capital Changes retreated to -$709403.0 in Q4 2025 per MNPR's latest filing, from $107242.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $621543.0 in Q1 2025 and troughed at -$709403.0 in Q4 2025.
- A 5-year average of -$12008.6 and a median of -$8273.5 in 2022 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 3720.59% in 2025, down 2484.39% in 2025.
- Over 5 years, Other Working Capital Changes stood at -$42087.0 in 2021, then surged by 76.86% to -$9738.0 in 2022, then jumped by 30.08% to -$6809.0 in 2023, then surged by 536.95% to $29752.0 in 2024, then slumped by 2484.39% to -$709403.0 in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$709403.0, $107242.0, and -$34786.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Monopar Therapeutics | 965.64 Mn | 912.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -709,403.00 |
| Dec 31, 2025 | -709,403.00 |
| Dec 31, 2025 | -709,403.00 |
| Sep 30, 2025 | 107,242.00 |
| Sep 30, 2025 | 107,242.00 |
| Sep 30, 2025 | 107,242.00 |
| Jun 30, 2025 | -34,786.00 |
| Jun 30, 2025 | -34,786.00 |
| Jun 30, 2025 | -34,786.00 |
| Mar 31, 2025 | 621,543.00 |
| Mar 31, 2025 | 621,543.00 |
| Mar 31, 2025 | 621,543.00 |
| Dec 31, 2024 | 29,752.00 |
| Dec 31, 2024 | 29,752.00 |
| Dec 31, 2024 | 29,752.00 |
| Sep 30, 2024 | -2,962.00 |
| Sep 30, 2024 | -2,962.00 |
| Sep 30, 2024 | -2,962.00 |
| Jun 30, 2024 | -49,871.00 |
| Jun 30, 2024 | -49,871.00 |